Cargando…

The ideal reporting of RAS testing in colorectal adenocarcinoma: a pathologists’ perspective

RAS gene mutational status represents an imperative predictive biomarker to be tested in the clinical management of metastatic colorectal adenocarcinoma. Even if it is one of the most studied biomarkers in the era of precision medicine, several pre-analytical and analytical factors may still impasse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malapelle, Umberto, Angerilli, Valentina, Pepe, Francesco, Fontanini, Gabriella, Lonardi, Sara, Scartozzi, Mario, Memeo, Lorenzo, Pruneri, Gianfranco, Marchetti, Antonio, Perrone, Giuseppe, Fassan, Matteo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore srl 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462993/ https://www.ncbi.nlm.nih.gov/pubmed/37314870 http://dx.doi.org/10.32074/1591-951X-895

Ejemplares similares

The Role of the Pathologist in the Next-Generation Era of Tumor Molecular Characterization
por: Angerilli, Valentina, et al.
Publicado: (2021)

Current molecular biomarkers evaluation in gastric/gastroesophageal junction adenocarcinoma: pathologist does matter
por: Businello, Gianluca, et al.
Publicado: (2022)

FGFR2 testing in cholangiocarcinoma: translating molecular studies into clinical practice
por: Angerilli, Valentina, et al.
Publicado: (2023)

FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint
por: Cappello, Filippo, et al.
Publicado: (2022)

Microsatellite Instable Colorectal Adenocarcinoma Diagnostics: The Advent of Liquid Biopsy Approaches
por: Ceccon, Carlotta, et al.
Publicado: (2022)

Claudin-18 expression in small bowel adenocarcinoma: a clinico-pathologic study
por: Arpa, Giovanni, et al.
Publicado: (2022)

Next-Generation Sequencing in Tumor Diagnosis and Treatment
por: de Biase, Dario, et al.
Publicado: (2020)

Special Issue: Next-Generation Sequencing in Tumor Diagnosis and Treatment II
por: Malapelle, Umberto, et al.
Publicado: (2022)

The GIPAD handbook of the gastrointestinal pathologist (in the Covid-19 era)
por: Parente, Paola, et al.
Publicado: (2020)

MicroRNAs as Predictive Biomarkers of Resistance to Targeted Therapies in Gastrointestinal Tumors
por: Angerilli, Valentina, et al.
Publicado: (2021)

Tumor immune microenvironment in therapy‐naive esophageal adenocarcinoma could predict the nodal status
por: Kotsafti, Andromachi, et al.
Publicado: (2022)

Pathologist’s approach to paediatric and neonatal eosinophilic gastrointestinal disorders
por: Campora, Michela, et al.
Publicado: (2022)

EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition
por: Rotella, Virginia, et al.
Publicado: (2014)

Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches
por: Mangogna, Alessandro, et al.
Publicado: (2023)

Negative Ultraselection of Patients With RAS/BRAF Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti–EGFR-Based Therapy
por: Randon, Giovanni, et al.
Publicado: (2022)

miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma
por: Zarrilli, Giovanni, et al.
Publicado: (2021)

Preoperative endoscopy and pathology report of the specimen to be recommended in sleeve gastrectomy?
por: Alessandris, Remo, et al.
Publicado: (2023)

The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences
por: Normanno, Nicola, et al.
Publicado: (2015)

Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network
por: Marchetti, Antonio, et al.
Publicado: (2021)

Sanger sequencing in routine KRAS testing: a review of 1720 cases from a pathologist's perspective
por: Malapelle, Umberto, et al.
Publicado: (2012)

The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment
por: Ziranu, Pina, et al.
Publicado: (2021)

Polymorphous low-grade adenocarcinoma: an analysis of epidemiological studies and hints for pathologists
por: de Araujo, Vera Cavalcanti, et al.
Publicado: (2013)

Intratumor morphologic and transcriptomic heterogeneity in (V600E)BRAF-mutated metastatic colorectal adenocarcinomas
por: Angerilli, V., et al.
Publicado: (2021)

Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study
por: Malapelle, Umberto, et al.
Publicado: (2020)

Problems for Pathologists
Publicado: (1876)

The Pathologist as Poet
por: Domen, Ronald E.
Publicado: (2016)

To be or not to be an oral pathologist
por: Ramesh, V
Publicado: (2019)

Pathologists’ Fees
Publicado: (1885)

Colorectal adenosquamous carcinoma: genomic profiling of a rare histotype of colorectal cancer
por: Angerilli, Valentina, et al.
Publicado: (2023)

HIMSS10 – Perspectives from a newcomer pathologist and a seasoned attendee pathologist: Pathologists should attend!
por: Carter, Alexis B., et al.
Publicado: (2010)

Survey Results on Pathologic Aspects of Endocervical Adenocarcinoma by the International Society of Gynecological Pathologists
por: McCluggage, W. Glenn, et al.
Publicado: (2021)

Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists
por: Park, Kay J., et al.
Publicado: (2021)

Review by urological pathologists improves the accuracy of Gleason grading by general pathologists
por: Nakai, Yasushi, et al.
Publicado: (2015)

Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes
por: Angerilli, Valentina, et al.
Publicado: (2022)

Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair–deficient metastatic colorectal cancer: Immunological and molecular profiling
por: Bergamo, Francesca, et al.
Publicado: (2022)

Association of Clinical Pathologists
Publicado: (2002)

The Relationship of the Pathologist to the Surgeon
Publicado: (1905)

Pathologist to the Edinburgh Infirmary
Publicado: (1902)

The Value of the Pathologist to the Surgeon
por: Davis, E. C.
Publicado: (1911)

Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers
por: Bruera, Gemma, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m14ra0td8780v03d7217e8r4lr